BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 2420896)

  • 1. Noninvasive Detection of iC3b/C3d Deposits in the Kidney Using a Novel Bioluminescent Imaging Probe.
    Renner B; Poppelaars F; Laskowski J; Serkova NJ; Kulik L; Holers VM; Thurman JM
    J Am Soc Nephrol; 2023 Jul; 34(7):1151-1154. PubMed ID: 36995143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.
    Wyatt AR; Zammit NW; Wilson MR
    Cell Stress Chaperones; 2013 Mar; 18(2):161-70. PubMed ID: 22896034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasminogen activation in plasma of patients with systemic lupus erythematosus.
    Negoro N; Kanayama Y; Takeda T; Fujisawa M; Okamura M; Inoue T
    Rheumatol Int; 1989; 8(6):273-7. PubMed ID: 2727550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
    Tamerius JD; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1985 Sep; 135(3):2015-9. PubMed ID: 2410510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of iC3b neoantigen expression in plasma from patients with systemic lupus erythematosus.
    Negoro N; Okamura M; Takeda T; Koda S; Amatsu K; Inoue T; Curd JG; Kanayama Y
    Arthritis Rheum; 1989 Oct; 32(10):1233-42. PubMed ID: 2803326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
    Garred P; Mollnes TE; Lea T; Fischer E
    Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassay.
    Mollnes TE; Lachmann PJ
    J Immunol Methods; 1987 Aug; 101(2):201-7. PubMed ID: 2440954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen.
    Kanayama Y; Kurata Y; McMillan R; Tamerius JD; Negoro N; Curd JG
    J Immunol Methods; 1986 Apr; 88(1):33-6. PubMed ID: 2420896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of complement in IgA nephropathy.
    Wyatt RJ; Julian BA
    Am J Kidney Dis; 1988 Nov; 12(5):437-42. PubMed ID: 3055972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3-dependent effector functions of complement.
    Zarantonello A; Revel M; Grunenwald A; Roumenina LT
    Immunol Rev; 2023 Jan; 313(1):120-138. PubMed ID: 36271889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Demonstration of C3-binding circulating immune complexes using Raji, conglutinin and anti-C3 assays--a critical review].
    Arndt R
    Immun Infekt; 1984 Feb; 12(1):3-11. PubMed ID: 6241918
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.